2 completed, 2 unknown, 1 terminated. 4 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Unknown 2, Completed 1, Terminated 1 |
| Phase 2 | 3 | Completed 2, Unknown 1 |
Follow Cardium Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Ad5FGF-4 for Myocardial Ischemia in Patients With Stable Angina Due to Coronary Artery Disease Alferminogene tadenovec - Angina, Stable | Phase 3 | Terminated | Cardium Therapeutics | 11 | 2012-03-01 | 2016-09-29 |
| Phase 2b Study of GAM501 in the Treatment of Diabetic Ulcers of the Lower Extremities GAM501, Placebo, Standard of care - Diabetic Foot | Phase 2 | Completed | Tissue Repair Company | 124 | 2007-11-01 | 2010-02-10 |
| Angiogenesis in Women With Angina Pectoris Who Are Not Candidates for Revascularization Ad5FGF-4, Placebo - Angina Pectoris | Phase 3 | Unknown | Cardium Therapeutics | 300 | 2007-05-01 | 2013-02-13 |
| Safety and Efficacy of Intracoronary Ad5FGF-4 in Patients With Stable Angina AdF5FGF-4 vs. Placebo - Stable Angina | Phase 2 / Phase 3 | Unknown | Cardium Therapeutics | 116 | 2002-03-01 | 2008-11-06 |
| Efficacy and Safety of Intracoronary Ad5FGF-4 in Patients With Stable Angina (AGENT-3) Ad5FGF-4 vs. Placebo - Angina Pectoris | Phase 2 / Phase 3 | Completed | Cardium Therapeutics | 416 | 2001-10-01 | 2012-02-09 |
Angina Pectoris (4) · Myocardial Ischemia (3) · Angina, Stable (2) · Cardiovascular Diseases (1) · Chest Pain (1) · Coronary Artery Disease (1) · Diabetes Mellitus (1) · Diabetic Foot (1) · Heart Diseases (1) · Ulcer (1)
Standard of Care (1)
United States (2) · Russia (1)
Paul Foster, MD (2) · Gabor Rubanyi (1) · Jeff Kittrelle, MD (1) · Robert Engler, MD (1)